Avenue Therapeutics, Inc.
(NASDAQ : ATXI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
-0.32%139.640.7%$1069.07m
PFEPfizer Inc.
-0.33%42.620.9%$907.62m
MRKMerck & Co., Inc.
0.27%83.000.6%$730.20m
BMYBristol-Myers Squibb Company
1.58%48.311.4%$540.14m
LLYEli Lilly and Company
0.47%112.271.0%$475.88m
ABBVAbbVie, Inc.
0.19%78.842.2%$357.02m
NVSNovartis AG Sponsored ADR
0.20%89.700.2%$198.39m
AZNAstraZeneca PLC Sponsored ADR
0.68%39.941.2%$112.08m
GSKGlaxoSmithKline plc Sponsored ADR
-0.47%39.930.2%$88.73m
NVONovo Nordisk A/S Sponsored ADR Class B
0.58%51.260.1%$73.95m
SNYSanofi Sponsored ADR
0.05%42.490.2%$73.17m
LCILannett Company, Inc.
2.68%5.3636.6%$4.84m
AKTXAkari Therapeutics Plc Sponsored ADR
-1.78%2.201.6%$0.36m
EPIXESSA Pharma Inc
0.88%2.300.1%$0.02m

Company Profile

Avenue Therapeutics, Inc. engages in acquiring, licensing, developing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, which is intended for the treatment of moderate to moderately severe post-operative pain. The company was founded on February 9, 2015 and is headquartered in New York, NY.